“…In conclusion, this updated meta-analysis, containing data from a further 22 studies published after the previous version (19), demonstrates a pooled prevalence of biopsy-proven CD of 3.3% among individuals with IBS-type symptoms, with a more than four-fold odds of CD, compared with healthy controls, and this was consistent across all IBS subtypes. Despite Adults (with 90% of participants aged >16 years) with a presumed diagnosis of IBS (either according to a clinician's opinion, questionnaire, after negative investigation(s), or meeting specific diagnostic criteria*).…”